Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Harbour BioMed Enters into a License and Collaboration Agreement with Moderna 2022-11-11 09:03
Antengene Presents Promising Results from Four Preclinical Studies at the 2022 Society for Immunotherapy of Cancer Annual Meeting 2022-11-11 08:30
Alma Academy was Successfully Held in Dubai with the Global Launch of Alma Duo 2022-11-10 23:57
CBC-backed ABio-X appoints pharmaceutical and healthcare veteran Dr. Jeffrey Jonas as CEO 2022-11-10 21:00
Asieris Obtained IND Approval from US FDA for APL-1401, a New Drug for the Treatment of Moderately-to-Severely Active Ulcerative Colitis 2022-11-10 19:02
Ascentage Pharma Announces IND Approval in China for Phase I Study of APG-5918 in Patients with Advanced Solid Tumors or Hematologic Malignancies 2022-11-10 11:36
Kintor Pharma Announces Oral Presentation at ASH 2022 Highlighting the Data from Novel Dual c-Myc/GSPT1 Degrader GT19715 2022-11-10 09:12
ALPINION MEDICAL SYSTEMS SHOWCASING THE LATEST INTELLIGENT ULTRASOUND TECHNOLOGY AT RSNA 2022 2022-11-10 04:50
Axiomtek launches the newest medical grade artificial intelligence computing system - mBOX100 2022-11-09 17:21
Amorepacific publishes its findings on dietary restrictions and lifespan extension in Nature Communications 2022-11-08 22:00
Traditional Chinese Medicine Lianhua Qingwen Attracted Eyes in the Annual National Conference of Pharmaceutical Society of Nigeria 2022-11-08 20:25
111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow 2022-11-08 14:09
Alterity Therapeutics Announces Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting 2022-11-07 23:25
National Institute of Korean Medicine shows a new trend in Korean Medicine in Times Square, New York 2022-11-07 23:00
SeekIn Demonstrates the Power of Treatment Response Monitoring Test at the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo 2022-11-07 21:00
Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research--Findings to be Presented at SITC 2022 2022-11-07 21:00
Ainos Reports Unaudited Third Quarter 2022 Financial Results 2022-11-07 20:30
Cordis promotes Alan Tsai as GM Greater China 2022-11-07 18:06
Preliminary Results from Two Clinical Studies of Selinexor to be Presented at 2022 ASH Annual Meeting 2022-11-07 14:38
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris, Completed the First Patient Dose in Phase III Trial 2022-11-07 10:04
1 105 106 107 108 109 432